SCHEMBL10891333

SCHEMBL10891333

CC1CC(NC(=O)C(F)(F)F)=NN1c1nc2c(s1)CCCC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.38
▸ SMN1; SMN2 Q16637 8/20 0.35
▸ HPGD P15428 2/20 0.35
▸ HTT P42858 1/20 0.35
▸ MAPT P10636 7/20 0.33
▸ RAB9A P51151 6/20 0.33
▸ TP53 P04637 6/20 0.33
▸ NPC1 O15118 5/20 0.33
▸ GAA P10253 4/20 0.33
▸ PKM P14618 3/20 0.33
▸ HSD17B10 Q99714 3/20 0.33
▸ LMNA P02545 3/20 0.33
▸ ABL1 P00519 2/20 0.33
▸ NFKB1 P19838 2/20 0.33
▸ NFKB2 Q00653 2/20 0.33
▸ RELA Q04206 2/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ ANO1 Q5XXA6 2/20 0.32
▸ HDAC3 O15379 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10891246 0.83 GAA (0.40) TSHRSMN1; SMN2HTTMAPTRAB9A
SCHEMBL10890235 0.78 TSHR (0.39) TSHRSMN1; SMN2HPGDHTTMAPT
SCHEMBL10894284 0.75 DRD3 (0.33) TSHRSMN1; SMN2RAB9ATP53NPC1
SCHEMBL13387645 0.72 PDK1 (0.36) TSHRMAPTRAB9ATP53NPC1
Evandamine SCHEMBL6009808 0.72 APOBEC3A (0.42) TSHRSMN1; SMN2HTTMAPTRAB9A
SCHEMBL6999293 0.70 TSHR (0.61) TSHRSMN1; SMN2HPGDHTTMAPT
SCHEMBL10891764 0.69 MEN1 (0.45) TSHRSMN1; SMN2MAPTRAB9ATP53
SCHEMBL11061030 0.69 ABL1 (0.50) GAALMNAABL1MEN1KMT2A
SCHEMBL11061324 0.68 ABL1 (0.55) MAPTRAB9ANPC1GAALMNA
SCHEMBL11060498 0.67 ABL1 (0.48) GAAABL1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4600722-A 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazolines and a process for the treatment of inflammatory or allergic processes in humans A. NATTERMANN & CIE GMBH (DE) 1986-07-15 — — US disclosed
EP-0155523-A1 3-Amino-1-(4,5,6,7-Tetrahydro-benzothiazolyl)-2-Pyrazolines,a process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-25 — — EP disclosed
Send feedback